MaxCyte Inc (MXCT) SEC News Jan. 12, 2026, 21:45 UTC (99% Neutral) MaxCyte Inc (MXCT) Reports Q1 2026 Financial Results Full text
Register to leave comments News bot Jan. 29, 2026, 6:50 p.m. 📋 MaxCyte Inc (MXCT) - Financial Results Filing Date: 2026-01-12 Accepted: 2026-01-12 16:45:48 Event Type: Financial Results Event Details: MaxCyte Inc (MXCT) Reports the reporting period Financial Results MaxCyte Inc (MXCT) announced its financial results for the period ending the reporting period. Key Financial Highlights: Revenue: $6 Net Income: Not disclosed EPS: Not disclosed Cash and equivalents: $155 📊 Key Financial Metrics: Metric Value Revenue $6 Cash $155 💼 Business Developments: PartnershipAcquisition: Not availableLicensing: Not availableRegulatory Approval: Not availableExecutive Changes: Not available Structured Data: Company Name: MaxCyte IncTicker Symbol: MXCT
📋 MaxCyte Inc (MXCT) - Financial Results
Filing Date: 2026-01-12
Accepted: 2026-01-12 16:45:48
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics:
💼 Business Developments:
Structured Data: